NP-111001 derivatives (Noscira)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameNP-111001 derivatives (Noscira)

Drug Alias Nametau phosphorylation inhibitors (Noscira)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMicrotubule-associated protein tau modulators

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNoscira Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNoscira Sa

Active IndicationsN/A

Inactive IndicationsAlzheimer Disease

ATC CodeN/A